Rare Disease Trial, Recruiting NCT04698421 Sponsor: University Hospital, Toulouse Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT04698421
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a neurological condition (a disorder affecting the brain, nerves, or nervous system) that is known or suspected to be caused by the immune system attacking the body, and this applies to both adults and children.
  • You have up-to-date health insurance or social security coverage.

Who may not be able to join:

  • Your neurological condition has been confirmed to be caused by something other than the immune system (i.e., autoimmune involvement has been ruled out).
  • You have been diagnosed with anemia and your hemoglobin level (a measure of red blood cells) is below 10 g/dl (confirm with trial site).
  • You are currently under a legal protection arrangement, such as guardianship or having a court-appointed guardian managing your affairs.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chloé Bost, PharmD, PhD, University Hospital, Toulouse

Phone: 5 61 77 61 44

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 October 2020
Est. completion
1 January 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Building a collection of biological samples and clinical-biological data from patients with rare autoimmune neurological diseases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov